181 related articles for article (PubMed ID: 16468517)
1. Use of recombinant factor VIIa for adjunctive hemorrhage control in trauma and surgical patients.
Benharash P; Bongard F; Putnam B
Am Surg; 2005 Sep; 71(9):776-80. PubMed ID: 16468517
[TBL] [Abstract][Full Text] [Related]
2. Recombinant activated coagulation factor VII and bleeding trauma patients.
Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
[TBL] [Abstract][Full Text] [Related]
3. The clinical and laboratory response to recombinant factor VIIA in trauma and surgical patients with acquired coagulopathy.
McMullin NR; Kauvar DS; Currier HM; Baskin TW; Pusateri AE; Holcomb JB
Curr Surg; 2006; 63(4):246-51. PubMed ID: 16843774
[TBL] [Abstract][Full Text] [Related]
4. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
[TBL] [Abstract][Full Text] [Related]
5. Recombinant activated factor VIIa use in massive transfusion and coagulopathy unresponsive to conventional therapy.
Gowers CJ; Parr MJ
Anaesth Intensive Care; 2005 Apr; 33(2):196-200. PubMed ID: 15960401
[TBL] [Abstract][Full Text] [Related]
6. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries.
Martinowitz U; Holcomb JB; Pusateri AE; Stein M; Onaca N; Freidman M; Macaitis JM; Castel D; Hedner U; Hess JR
J Trauma; 2001 Apr; 50(4):721-9. PubMed ID: 11303171
[TBL] [Abstract][Full Text] [Related]
7. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
[TBL] [Abstract][Full Text] [Related]
8. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
[TBL] [Abstract][Full Text] [Related]
9. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.
Rizoli SB; Boffard KD; Riou B; Warren B; Iau P; Kluger Y; Rossaint R; Tillinger M;
Crit Care; 2006; 10(6):R178. PubMed ID: 17184516
[TBL] [Abstract][Full Text] [Related]
10. Recombinant activated factor VII for the treatment of life-threatening haemorrhage.
Eikelboom JW; Bird R; Blythe D; Coyle L; Gan E; Harvey M; Isbister J; Leahy M; McIlroy D; Rahimpanah F; Ramanthan S; Strasser S; Ward C; Watts A; Towler S; Yi Q
Blood Coagul Fibrinolysis; 2003 Dec; 14(8):713-7. PubMed ID: 14614349
[TBL] [Abstract][Full Text] [Related]
11. Recombinant factor VIIa in the treatment of bleeding.
Midathada MV; Mehta P; Waner M; Fink LM
Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
[TBL] [Abstract][Full Text] [Related]
12. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Murkin JM
Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
[TBL] [Abstract][Full Text] [Related]
13. Current evidence based guidelines for factor VIIa use in trauma: the good, the bad, and the ugly.
Duchesne JC; Mathew KA; Marr AB; Pinsky MR; Barbeau JM; McSwain NE
Am Surg; 2008 Dec; 74(12):1159-65. PubMed ID: 19097529
[TBL] [Abstract][Full Text] [Related]
14. Recombinant activated factor VII for adjunctive hemorrhage control in trauma.
Martinowitz U; Kenet G; Segal E; Luboshitz J; Lubetsky A; Ingerslev J; Lynn M
J Trauma; 2001 Sep; 51(3):431-8; discussion 438-9. PubMed ID: 11535886
[TBL] [Abstract][Full Text] [Related]
15. The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries.
Schreiber MA; Holcomb JB; Hedner U; Brundage SI; Macaitis JM; Hoots K
J Trauma; 2002 Aug; 53(2):252-7; discussion 257-9. PubMed ID: 12169930
[TBL] [Abstract][Full Text] [Related]
16. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
17. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
[TBL] [Abstract][Full Text] [Related]
18. Treatment of critical bleeding in trauma patients.
Chiara O; Cimbanassi S; Brioschi PR; Bucci L; Terzi V; Vesconi S
Minerva Anestesiol; 2006 Jun; 72(6):383-7. PubMed ID: 16682905
[TBL] [Abstract][Full Text] [Related]
19. Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion.
Perkins JG; Schreiber MA; Wade CE; Holcomb JB
J Trauma; 2007 May; 62(5):1095-9; discussion 1099-101. PubMed ID: 17495707
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIIa and the surgical patient.
Scarpelini S; Rizoli S
Curr Opin Crit Care; 2006 Aug; 12(4):351-6. PubMed ID: 16810047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]